These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28594475)

  • 1. What is safety?: Miracles, benefit-risk assessments, and the "right to try".
    DeTora LM
    Int J Clin Pract; 2017 Jul; 71(7):. PubMed ID: 28594475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free to Choose: A Moral Defense of the Right-to-Try Movement.
    Brodrick M
    J Med Philos; 2020 Jan; 45(1):61-85. PubMed ID: 31922578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk-benefit evaluation of medicinal products. An element of Health Technology Assessment].
    Hart D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):204-14. PubMed ID: 15726462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unproven stem cell therapies: is it my right to try?
    Riva L; Campanozzi L; Vitali M; Ricci G; Tambone V
    Ann Ist Super Sanita; 2019; 55(2):179-185. PubMed ID: 31264641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.
    Lantos JD; Wendler D; Septimus E; Wahba S; Madigan R; Bliss G
    Clin Trials; 2015 Oct; 12(5):485-93. PubMed ID: 26374686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to achieve safe, high-quality clinical studies with non-Medicinal Investigational Products? A practical guideline by using intra-bronchial carbon nanoparticles as case study.
    Berger M; Kooyman PJ; Makkee M; van der Zee JS; Sterk PJ; van Dijk J; Kemper EM
    Respir Res; 2016 Aug; 17(1):102. PubMed ID: 27542842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.
    Serabian MA; Pilaro AM
    Toxicol Pathol; 1999; 27(1):27-31. PubMed ID: 10367669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On Patient Safety: A Right to Try, Not Exploit.
    Rickert J
    Clin Orthop Relat Res; 2021 Jul; 479(7):1435-1437. PubMed ID: 34086009
    [No Abstract]   [Full Text] [Related]  

  • 15. The ethical plausibility of the 'Right To Try' laws.
    Carrieri D; Peccatori FA; Boniolo G
    Crit Rev Oncol Hematol; 2018 Feb; 122():64-71. PubMed ID: 29458791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Running an ethical trial 60 years after the Nuremberg Code.
    Markman JR; Markman M
    Lancet Oncol; 2007 Dec; 8(12):1139-1146. PubMed ID: 18054883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The imminent peril in the law of July the fifth 2011, two years later: the impact on health?].
    Mondoloni A; Buard M; Nargeot J; Vacheron MN
    Encephale; 2014 Dec; 40(6):468-73. PubMed ID: 24703930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.
    Leonard EW
    J Law Med Ethics; 2009; 37(2):269-79. PubMed ID: 19493072
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.